---
figid: PMC9641161__etm-24-06-11670-g00
pmcid: PMC9641161
image_filename: etm-24-06-11670-g00.jpg
figure_link: /pmc/articles/PMC9641161/figure/f1-ETM-24-6-11670/
number: Figure 1
figure_title: ''
caption: 'Expression levels of CSPG4P12 in NSCLC and adjacent normal tissues. (A)
  CSPG4P12 expression in NSCLC tissues as predicted using the gene expression profiling
  interactive analysis database. The graph represents the following: 483 LUAD tissues
  (red) and 347 adjacent normal tissues (gray); 486 LUSC tissues (red) and 338 adjacent
  normal tissues (gray). (B) Reverse transcription-quantitative PCR analysis of CSPG4P12
  expression in NSCLC tissues and adjacent normal tissues. *P<0.05 and **P<0.01. CSPG4P12,
  chondroitin sulfate proteoglycan 4 pseudogene 12; NSCLC, non-small cell lung cancer;
  LUAD, lung adenocarcinoma. LUSC, lung squamous cell carcinoma.'
article_title: Pseudogene CSPG4P12 affects the biological behavior of non‑small cell
  lung cancer by Bcl‑2/Bax mitochondrial apoptosis pathway.
citation: Wenqian Hu, et al. Exp Ther Med. 2022 Dec;24(6):734.
year: '2022'

doi: 10.3892/etm.2022.11670
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- non-small cell lung cancer
- chondroitin sulfate proteoglycan 4 pseudogene 12
- long non-coding RNA
- mitochondrial apoptosis
- p53/Bcl2/Bax pathway
- pseudogene

---
